These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37640625)

  • 1. Rationale and design of the ARAMIS trial: Anakinra versus placebo, a double blind randomized controlled trial for the treatment of acute myocarditis.
    Kerneis M; Cohen F; Combes A; Amoura Z; Pare C; Brugier D; Puymirat E; Abtan J; Lattuca B; Dillinger JG; Hauguel-Moreau M; Silvain J; Salem JE; Gandjbakhch E; Hekimian G; Redheuil A; Vicaut E; Montalescot G;
    Arch Cardiovasc Dis; 2023 Oct; 116(10):460-466. PubMed ID: 37640625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.
    Maes B; Bosteels C; De Leeuw E; Declercq J; Van Damme K; Delporte A; Demeyere B; Vermeersch S; Vuylsteke M; Willaert J; Bollé L; Vanbiervliet Y; Decuypere J; Libeer F; Vandecasteele S; Peene I; Lambrecht B
    Trials; 2020 Jun; 21(1):468. PubMed ID: 32493441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins.
    Maisch B; Hufnagel G; Kölsch S; Funck R; Richter A; Rupp H; Herzum M; Pankuweit S
    Herz; 2004 Sep; 29(6):624-36. PubMed ID: 15912438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST-Segment-Elevation Myocardial Infarction.
    Abbate A; Trankle CR; Buckley LF; Lipinski MJ; Appleton D; Kadariya D; Canada JM; Carbone S; Roberts CS; Abouzaki N; Melchior R; Christopher S; Turlington J; Mueller G; Garnett J; Thomas C; Markley R; Wohlford GF; Puckett L; Medina de Chazal H; Chiabrando JG; Bressi E; Del Buono MG; Schatz A; Vo C; Dixon DL; Biondi-Zoccai GG; Kontos MC; Van Tassell BW
    J Am Heart Assoc; 2020 Mar; 9(5):e014941. PubMed ID: 32122219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 study.
    Van Tassell B; Mihalick V; Thomas G; Marawan A; Talasaz AH; Lu J; Kang L; Ladd A; Damonte JI; Dixon DL; Markley R; Turlington J; Federmann E; Del Buono MG; Biondi-Zoccai G; Canada JM; Arena R; Abbate A
    J Transl Med; 2022 Jun; 20(1):270. PubMed ID: 35706006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of cannabidiol on myocardial recovery in patients with acute myocarditis: Rationale & design of the ARCHER trial.
    McNamara DM; Cooper LT; Arbel Y; Bhimaraj A; Bocchi E; Friedrich MG; Kerneis M; Liu P; Parker AB; Smith ER; Tang WHW; Torre-Amione G; Tschöpe C;
    ESC Heart Fail; 2024 Jun; ():. PubMed ID: 38937900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial.
    Vallejos J; Zoni R; Bangher M; Villamandos S; Bobadilla A; Plano F; Campias C; Chaparro Campias E; Achinelli F; Guglielmone HA; Ojeda J; Medina F; Farizano Salazar D; Andino G; Ruiz Diaz NE; Kawerin P; Meza E; Dellamea S; Aquino A; Flores V; Martemucci CN; Vernengo MM; Martinez SM; Segovia JE; Aguirre MG
    Trials; 2020 Nov; 21(1):965. PubMed ID: 33234158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101--Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trastuzumab-mediated left ventricular remodeling among patients with HER2+ early breast cancer using cardiac MRI.
    Pituskin E; Haykowsky M; Mackey JR; Thompson RB; Ezekowitz J; Koshman S; Oudit G; Chow K; Pagano JJ; Paterson I
    BMC Cancer; 2011 Jul; 11():318. PubMed ID: 21794114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin for presumed viral myocarditis in children and adults.
    Robinson J; Hartling L; Vandermeer B; Sebastianski M; Klassen TP
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD004370. PubMed ID: 32835416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-perspective: the ARAMIS double-blind randomized placebo-controlled trial of anakinra for the treatment of acute myocarditis.
    Morrow DA; Verbrugge FH
    Eur Heart J Acute Cardiovasc Care; 2023 Sep; 12(9):627-628. PubMed ID: 37648656
    [No Abstract]   [Full Text] [Related]  

  • 17. Interleukin-1 blockade in cardiac sarcoidosis: study design of the multimodality assessment of granulomas in cardiac sarcoidosis: Anakinra Randomized Trial (MAGiC-ART).
    Kron J; Crawford T; Mihalick V; Bogun F; Jordan JH; Koelling T; Syed H; Syed A; Iden T; Polly K; Federmann E; Bray K; Lathkar-Pradhan S; Jasti S; Rosenfeld L; Birnie D; Smallfield M; Kang L; Fowler AB; Ladd A; Ellenbogen K; Van Tassell B; Gregory Hundley W; Abbate A
    J Transl Med; 2021 Nov; 19(1):460. PubMed ID: 34749739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D-HART2).
    Van Tassell BW; Buckley LF; Carbone S; Trankle CR; Canada JM; Dixon DL; Abouzaki N; Oddi-Erdle C; Biondi-Zoccai G; Arena R; Abbate A
    Clin Cardiol; 2017 Sep; 40(9):626-632. PubMed ID: 28475816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial.
    Makkar RR; Kereiakes DJ; Aguirre F; Kowalchuk G; Chakravarty T; Malliaras K; Francis GS; Povsic TJ; Schatz R; Traverse JH; Pogoda JM; Smith RR; Marbán L; Ascheim DD; Ostovaneh MR; Lima JAC; DeMaria A; Marbán E; Henry TD
    Eur Heart J; 2020 Sep; 41(36):3451-3458. PubMed ID: 32749459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.
    Barco S; Bingisser R; Colucci G; Frenk A; Gerber B; Held U; Mach F; Mazzolai L; Righini M; Rosemann T; Sebastian T; Spescha R; Stortecky S; Windecker S; Kucher N
    Trials; 2020 Sep; 21(1):770. PubMed ID: 32907635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.